Presentation TCT 2017 TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation Presenter: Armando Tellez, MD October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Maria Del Trigo, MD October 31, 2017
Presentation TCT 2017 TCT 49: Long-Term Valve Function 5-9 Years After Transcatheter Aortic Valve Implantation: Data From the UK-TAVI Registry. On Behalf of the National Institute for Cardiovascular Outcomes Research (NICOR) Presenter: Daniel J. Blackman October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: David J. Cohen October 31, 2017
Presentation TCT 2017 Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support? Presenter: Stephane Noble October 31, 2017
Presentation TCT 2017 Korea Presents: A Case of Valve-in-Valve TAVR Presenter: Bon-Kwon Koo October 31, 2017
Presentation TCT 2017 Case Comments: How Should We Manage This Patient? Presenter: Roman Tarasov October 31, 2017
Presentation TCT 2017 Case Comments: What Does the Literature Tell Us? Presenter: Margaret B. McEntegart October 31, 2017
Presentation TCT 2017 Case Comments: What Antithrombotic/Antiplatelet Regimen Should We Start? Presenter: Alexey Protopopov October 31, 2017